Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Endocyte, Inc. Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 4.15||$ 6.35|
|Low||$ 3.80||$ 2.65|
The current last sale of $3.90 is 47.17% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. We use our proprietary technology to create novel small molecule drug conjugates, or SMDCs, and companion imaging agents. Our SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone. We are also developing companion imaging agents for each of our SMDCs that are designed to identify the patients whose disease over-expresses the target of the therapy and who are therefore likely to benefit from treatment. ... More ...
Where does ECYT fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-0.98|
|Quarterly EPS Est:||-0.26|